S&P 500 cuts losses as Nvidia climbs ahead of results
LONDON - Dr. Martens PLC (LSE:DOCS) announced on Thursday that shareholders approved all 22 resolutions presented at its Annual General Meeting, with most measures receiving overwhelming support.
The iconic British footwear maker reported that all proposed resolutions passed with significant majorities. The final dividend received near-unanimous approval with 100% of votes cast in favor, while the company’s annual report and accounts were similarly endorsed with 100% support.
Among the key approved measures were the election of new board members Ije Nwokorie and Benoit Vauchy, who received 90.49% and 90.36% of votes respectively. Robert Hanson was elected with 99.98% support.
Shareholders also approved the removal of the 5% dilution limit for discretionary share plans with 99.87% of votes in favor. The reappointment of PricewaterhouseCoopers LLP as the company’s auditor passed with 99.99% support.
Special resolutions authorizing the general disapplication of pre-emption rights and additional disapplication of pre-emption rights were approved with 94.86% and 94.74% of votes respectively. The authorization for the company to purchase its own shares received 98.19% support.
The meeting saw strong shareholder participation, with 81.38% of the company’s voting capital represented for most resolutions.
Dr. Martens, founded in 1960, operates in over 60 countries and employs more than 3,650 people worldwide. The company sells its products through both direct-to-consumer and wholesale channels.
This article is based on a press release statement from Dr. Martens PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.